|Day Low/High||61.81 / 62.88|
|52 Wk Low/High||49.03 / 86.31|
Action Alerts PLUS holdings are preparing for a smartphone showdown, while fellow holding Walgreens could see a boost to earnings.
Rite Aid shares are up Thursday after posting second quarter earnings of $0.03 a share, a penny ahead of forecasts.
U.S. stocks rose on Thursday, fueled by the Federal Reserve's decision Wednesday to keep interest rates lower for longer.
Earnings and economic data are in focus for Thursday, September 22.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer isn't fond of how Rite Aid is being managed.
The recent selloff doesn't track the strong economics of the business.
McKesson is down 10 percent year-to-date due to the heated political debate over drug pricing but the stock is too cheap to ignore.
Disappointment over the ECB's inaction and uncertainty over the Fed's rate plans left markets rattled.
Oil stocks surge on EIA data, while Rite Aid and Walgreens continue to push their pending deal forward.
Shares of Kroger were lower Wednesday. The supermarket chain has emerged as a buyer for stores of Rite Aid.
Jim Cramer says it's too early to buy grocery store stocks like Sprouts and Kroger.
U.S. stock losses accelerated throughout the morning after a reading on manufacturing activity in the U.S. fell into contraction.
Accounting irregularities lead to some troubling scenarios.
It's apparently not all doom and gloom in the private-equity realm of stock picking these days.
Appaloosa adds to its stake in the biopharmaceutical company while Jana Partners exits its position.
Macy's plans to close stores and Jim Cramer thinks the stock is one to trade.
Names that shareholders should watch are those where PE firms hold big stakes in their companies.
Ralph Lauren shares surge on earnings beat amid lethargic market action.
Plus, hats off to Fill or Kill on Lululemon.
Analysts say Tuesday's earnings beat could spell trouble in terms of coping with its $31 billion worth of debt.
All eyes will be on whether the drug company cuts its earnings guidance in tomorrow's earnings release.
It has had a long correction, but a resolution up or down is coming
The Canadian drugmaker could again be hit by its unprofitable Walgreens deal as earnings loom.
U.S. stocks struggle to hold onto slight gains after a terrorist attack overnight casts a shadow over global markets.
Herbalife stock lifted on FTC investigation results while Xerox reportedly rejects R.R. Donnelley's merger proposal.
Costco and Zumiez were able to benefit from their strong June comps, while Walgreens Buckle and L Brands went the other way.
U.S. stocks shook off earlier weakness to close higher after the Fed's June meeting minutes stressed a prudent approach to monetary policy.
U.S. stocks moved lower on Wednesday, as Brexit fears pushed investors into safe-haven assets.